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1. Introduction 
Cardiovascular diseases is the most common cause of death worldwide and coronary artery 
disease (CAD) still remains the leading cause of death in Latvia. The incidence of CAD in 
Europe is 20-40 thousands per one million people (Fox et al., 2006).  According to the data of 
Health Statistics and Medical Technology Agency in Latvia 16 079 individuals died due to 
cardiovascular disease in 2009 (54% of total mortality rate). Mortality rate due to CAD is 
three times higher in Latvia than average in European Society in individuals group younger 
than 64 years. The loss of productive years of life has negative influence neither to private, 
nor public economical sector. 
The common electrocardiographic finding on exercise stress test, which can be evident for 
CAD, is recurrent, load-induced ST-segment depression. It points to myocardial ischemia in 
patient with significantly narrowed coronary arteries in status of progressive oxygen 
demand, while at rest blood flow is not limited. The sensitivity of the stress test increases 
along with severity of disease. It is possible correctly to identify the patients with proximal 
several arteries disease or left main artery stenosis performing a standard exercise stress test, 
nevertheless it gives unsufficient prognostic information in patient with less severe 
obstructive disease. 
Progression of coronary artery restenosis after percutaneous coronary intervention (PCI) is a 
clinical “final” result, which reflects complex pathophysiological process, including different 
combinations of residual coronary stenosis and neointimal proliferation. Unfortunately, the 
set of clinical symptoms is uncertain criteria for detection of coronary artery restenosis, 
patient’s complaints could be similar to non-coronary pain post revascularization (‘false-
positive’ symptoms), at the same time – “silent” ischemia may be present in many patients 
(‘pseudo-negative’ symptoms). Restenosis is observed in 25% of cases (data of balloon 
angioplasty) in asymptomatic patients with documented ischemic changes on exercise test 
(Bengston et al., 1990). 
Discussions are still extended, whether early performed strategy of exercise test is with 
prognostic value for clinical events in patients after PCI. There are no conclusive results 
about association of complaints’ limited exercise tests and long-term prognosis early after 
PCI. 
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CAD patients with left main coronary artery (LM) stenosis is another one group of interest, 
and there is stable introduced invasive PCI treatment and stent implantation for this 
patients’ group. It is important to evaluate the efficacy of new treatment, outcomes and 
following risk of cardiovascular events. Patients after LM PCI are at higher risk of 
thrombosis and restenosis, angiographic follow-up of these patients is expensive enough, 
with additional radiation dose and contrast amount for patients. Thus, high attention is 
focused on non-invasive investigation methods in patients with CAD. 
The results of recent studies should be taken into account, that the higher risk of 
cardiovascular events is observed in patients with unstable atheromatous plaque, even in 
case if stenosis of coronary artery is not significant (in segment of this plaque location). 
Exercise test in this situation should be evaluated more precisely and seriously in order to 
improve the prognostic value of the method. The question is – whether exercise test (with 
electrocardiogramm (ECG)) can be used in evaluation of prognostic criteria for patient along 
with possibility to detect obstructive lesion of coronary arteries with a goal to decrease 
effectively the risk of sudden death and serious coronary events? 
2. Objective of the study  
The aim of the study was to evaluate effectiveness of medical and invasive treatment in 
patients with CAD after PCI by performing physical test and proving test prognostic value 
of cardiovascular events - clinical (myocardial infarction, recurrent hospitalization, cardiac 
death) and angiographic (restenosis and/or new stenosis of coronary arteries) events. 
The main goals were defined: 
1. to define specific criteria of exercise stress test for possible restenosis diagnostics; 
2. to develop the algorhythm for the patients’ functional status evaluation after PCI, as 
well as for evaluation the possibility of coronary artery stenosis correction 
(intervention); 
3. to create the prognostic model, which can help to evaluate and reveal the patients with 
unfavorable long-term outcomes or unsatisfactory treatment results timely; 
4. to integrate targeted follow-up patients’ programme.  
3. Materials and methods 
The follow-up programme was developed in 1990 in the Latvian Centre of Cardiology and 
surveyed patients with CAD which underwent PCI treatment method. 
The programme has been proceeded since the first patient was treated with the method of 
coronary angioplasty in Latvia. 
The study was implemented from January, 2004 till January, 2009. The patients with 
established CAD (based on coronary angiography data) were included in the study. The 
patients underwent invasive treatment – PCI in the Latvian Centre of Cardiology. The 
number of performed PCIs during mentioned period of time – 16 109. All patients were 
informed about possibility to be included in the follow-up programme. 
The data of 7 300 patients with CAD and complete 24-months follow-up after PCI were 
included in the study. 
The patients were observed in defined follow-up periods of time after PCI by performing 
exercise stress test (veloergometry – bicycle ergometer exercise test): 
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 1-3 months after invasive treatment – immediate risk evaluation and correction of 
medical treatment; 
 3-6 months after PCI – distant period – determination of possibility of restenosis and 
correction of medical treatment; 
 12-24 months after PCI – late period – determination of possibility of restenosis and 
correction of medical treatment. 
Control coronary angiography was performed based on indications, which included 
following patients groups: 
 patients with new-onset angina proved by ischemic changes on ECG during exercise 
stress test; 
 patients without typical coronary complaints, but with registered ischemic changes on 
exercise test ECG; 
 patients with non-sufficient information on exercise test in order to evaluate indications 
for coronary angiography, therefore exercise test with additional visualization method 
was performed – myocardial perfusion scintigraphy. 
 Patients without indications for control coronary angiography underwent the correction 
of medical treatment (if it was needed) and were included in the next scheduled 
exercise test control. 
Large patients group was revealed during the follow-up process – patients without typical 
coronary chest pain but with registered ischemic changes on ECG during exercise test. These 
patients were defined like „silent” ischemia patients group which has the higher risk of 
cardiovascular events and worse prognosis. 
All the patients of this group underwent control coronary angiography and were divided 
into different groups according to angiographic finding: 
 patients with restenosis of coronary artery (in previously repaired segment); 
 patients with new stenosis of coronary artery; 
 patients without restenosis or new stenosis on angiographic finding.  
Patients with restenosis or new stenosis underwent PCI and were included in consequent 
follow-up plan and medical treatment correction. Patients without restenosis or new 
stenosis continued previously defined follow-up plan. 
The analysis of used medications groups was performed because of medical treatment 
correction during follow-up process. It was dependent on obtained data during exercise test 
(e.g., arterial blood pressure and/or heart rate, compliance of these parameters changes to 
physical load, etc.). Medications after performed PCI (recommended on discharge) and in 
one year follow-up period were compared. 
Very high risk patients were included into the separate group analysis (400 patients) with 
LM stenotic lesion. All patients were informed about possibility to be included in the 24 
months follow-up plan. 133 patients have accomplished complete follow-up programme (1, 
3, 6, 12 and 24 months after PCI). In order to define precise indications for control coronary 
angiography, myocardial perfusion scintigraphy with physical or pharmacological test was 
performed in this patients group (94 examinations). This examination was performed in 12-
24 months period after PCI in patients without indications for control angiography. 
Phone follow-up survey was also performed in this patients group in order to clarify 
possible coronary events – hospitalization, myocardial infarction or death. Patients groups 
with and without performed follow-up programme were compared. 
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SPSS 12.0.1. version was used for statistical analyses. Baseline characteristics were 
summarized as frequencies and percentages for categorical variables and as means and SDs 
for continuous variables. Analyses were performed using χ2/Fisher exact test for categorical 
variables and Student t test/ ANOVA method for continuous variables. The correction with 
Tukey test was performed in post hoc analysis for multiple comparisons correction. 
Differences were considered statistically significant at p<0.05. 
3.1 Exercise test – veloergometry  
Exercise stress test – veloergometry was performed in sitting or reclining position in patients 
of the study, depending on used bicycle ergometer (in sitting position – veloergometer 
„Ergometrs 900” and since April, 2008 – veloergometer „e-bike” for test performing in 
reclining position). Modified Bruce protocol was used during exercise test – standardized 
load grading programme according to the protocol accepted by Latvian Cardiology Society:     
 first degree – three minutes with 50 Watt (W) load; 
 second degree – three minutes with 100 W load; 
 third degree – three minutes with 150 W load; 
 fourth degree – three minutes with 200 W load; 
 fifth degree – three minutes with 250 W load. 
Maximal allowed load was defined as 250 W. In specific cases (if it was necessary) or 
according to patient condition (patients with chronic heart failure) the protocol was 
accommodated individually – the load was increased for 25 W every three minutes with the 
beginning of second degree of the test protocol.  
ECG was monitored continuously during the test time, increasing the load till the goal heart 
rate was achieved – 85 % of maximal heart rate according (appropriate) to concrete age or 
the load was limited by symptoms of ischemia.  
Following indications were defined for the test discontinuation: 
a. typical increasing chest pain and/or ST-segment changes on ECG (ST-segment 
depression > 2 mm – as a relative indication for the test interruption, ST-segment 
depression > 3 mm – as a absolute indication for the test interruption); 
b. ST-segment elevation > 1 mm (if pathologic Q-wave is not present on ECG at rest); 
c. arrhythmias (supraventricular tachycardia, multiple politope and pair premature beats 
(extrasystoles)); 
d. systolic blood pressure decrease (> 10 mmHg compared with onset blood pressure 
level), despite of the load increase; 
e. hypertension (> 250 mmHg systolic and > 115 mmHg diastolic blood pressure); 
f. central nervous system symptoms (ataxy, weakness, syncope); 
g. signs of decreased perfusion (cyanosis); 
h. fatigue, dyspnoe, leg cramps, claudication; 
i. complete left His bundle branch block; 
j. achieved submaximal heart rate; 
k. patient’s request to terminate the test; 
l. technical problems. 
Exercise test was defined as positive, if there were registered changes on ECG associated 
with myocardial ischemia: 
 horizontal or downslopping ST-segment depression or elevation, greater than or equal 
with 1 mm 60 msec after QRS complex; 
www.intechopen.com
 
The Role of Exercise Test After Percutaneous Coronary Intervention 
 
249 
 especially, if these changes were associated with chest pain, appeared at lower load (< 
75 W) and lasting for more than 3 minutes after load was finished. 
Following parameters were analized:   
a. Electrocardiographic parameters: 
- maximal ST-segment depression; 
- maximal ST-segment elevation; 
- configuration (shape) of ST-segment depression (horizontal, downslopping, 
upslopping); 
- the number of leads ST-segment changes registered in; 
- duration of ST-segment changes at the test phase of rest (after load discontinued); 
- ST/pulse index; 
- ventricular arrhythmias induced by exercise; 
- the time to ST-segment changes appeared at. 
b. Hemodynamic parameters: 
- maximal heart rate; 
- maximal systolic blood pressure; 
- maximal double rate-pressure product (Robinson index) (maximal heart rate 
multiply by maximal systolic arterial pressure, divided by 100) 
- total exercise (load) time; 
- hypotension (arterial pressure decrease under the blood pressure level before load 
was started); 
- chronotropic incompetence. 
c. Symptomatic parameters: 
- angina provoked by load; 
- load-limiting symptoms; 
- time to the onset of angina.  
Following information was included in the protocol of veloergometry (accordingly the 
methodological guidelines): 
 maximal load; 
 total time of the load; 
 heart rate at the beginning; 
 initial systolic and diastolic blood pressure; 
 maximal heart rate; 
 maximal systolic and diastolic blood pressure; 
 double rate-pressure product; 
 the intensity and quantity of ECG changes; 
 recovering period after load; 
 patient’s complaints; 
 test termination reasons; 
 tolerance of the exercise (load) (high, satisfactory, lowered, low); 
 load-limiting factors. 
The data mentioned above (collected from veloergometry test protocols) were included into 
the total database of the study. 
There were no any complications registered during exercise test perfoming – myocardial 
infarction, life-threating arrhythmias or death. 
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Myocardial perfusion scintigraphy was perfomed in patients at the case of embarrassing 
interpretation of ECG, and in order to evaluate the indications for control coronary 
angiography. 
Myocardial perfusion scintigraphy was also performed in patients after LM PCI. 
3.2 Coronary angiography and PCI 
The information about atherosclerotic lesions degree of coronary arteries was collected and 
included into the total database of the study (based on coronary angiography finding). 
Follow-up period results were included – data of coronary angiography finding (restenosis 
and/or new stenosis of coronary artery(-ies)), acute coronary events (recurrent 
hospitalization, myocardial infarction, coronary artery bypass grafting, recurrent coronary 
angiography and/ or PCI). 
The result of revascularization was defined, basing on the data of coronary angiography 
finding: 
- successful PCI defined as a dilatation of coronary artery stenosis with complete 
revascularization, if residual stenosis of coronary artery(-ies) does not exceed 50 % 
(Wenaweser et al., 2008); 
- incomplete revascularization defined as a residual stenosis (narrowing of the lumen of 
artery after performed PCI) greater than or equal with 50 % in any coronary artery 
(Chalela et al., 2006). 
Restenosis of coronary artery at the follow-up period was defined as a narrowing of 
coronary artery(-ies) lumen greater than or equal with 50 % and progression of coronary 
artery disease, if new stenosis of coronary artery was diagnosed (Chalela et al., 2006). 
4. Results 
4.1 Data registry of the patients with coronary artery disease treated with PCI 
In total 7300 patients with established CAD and performed treatment with PCI, with 
complete follow-up programme – 1, 3, 6 and 12 months follow-up visits, were included into 
the study. The patients underwent physical stress test, correction of used medications plan 
and doses of drugs, if it was necessary, and the control of risk factors. Control coronary 
angiography was performed in 2583 patients accordingly the indications.  
Indications for performance of control coronary angiography were determined basing on 
exercise test (13% of cases), restenosis on angiography was detected in 6.4% of the total 
patients’ group. 
In the patients’ group with left main artery stenosis (LM group) 400 patients were observed, 
133 of them worked out complete follow-up program and underwent control coronary 
angiography. Myocardial perfusion scintigraphy was performed in 98 LM-patients in order 
to evaluate more precisely the indications for coronary angiography. 
In total patients’ group 1226 patients (17%) showed coronary complaints, and ST-segment 
changes on ECG, which could be associated with myocardial ischemia, were observed in 975 
patients (13% of total number of patients). According to the indications these patients 
underwent coronary angiography. In general, angiographically confirmed coronary artery 
restenosis was diagnosed in 470 patients (6.4%) of all controlled patients’ group (7300) 
(Figure 1.). 
www.intechopen.com
 
The Role of Exercise Test After Percutaneous Coronary Intervention 
 
251 
 
Fig. 1. Results of the follow-up programme (the total number of the patients – 7300). 
Exercise test is useful in detection of patients with „silent” ischemia (22%), which have 
the indications for control angiography; restenosis is found in 9% of this patients group. 
 
 
Fig. 2. Patients with „silent” ischemia. 
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It was observed during patients follow-up, that a separate group of the patients is forming, 
which is characterized by no complaints of chest pain, but significant ST-segment changes 
on exercise test ECG (so-called, silent ischemia, poor prognostic factor). These are 22% of the 
patients (1608 patients), all of them underwent coronary angiography. Restenosis of 
coronary artery was detected in 656 patients (9% of the total number of patients) and new 
hemodinamically significant stenosis in coronary artery (> 50% of artery lumen) – in 146 
patients (2%) of this patients group (Figure 2.). 
4.2 New specific criteria in restenosis diagnostics 
Several new specific criteria were found in restenosis diagnostics field additionally to ST-
segment ischemic changes on ECG during exercise stress test – reduced load tolerance, 
decreased maximal heart rate and maximal systolic blood pressure, maximal rate-pressure 
product (double product) – Robinson index, also increased ST/pulse index (ST/p index). 
Differences in parameters derived from exercise tests in patients with restenosis, new 
stenosis and in patients without restenosis/new stenosis on coronary angiography are 
shown in Figure 3.   
 
 
Fig. 3. Results of exercise test in „silent” ischemia patients’ group.  
Patients with restenosis on coronary angiography (first group) showed definitely ischemic 
changes on exercise ECG at lower physical load 121.4±33.2 W compared with those patients’ 
group with neither restenosis, nor new stenosis on coronary angiography (third group) – 
160.0±25.8 W (p<0.05). Achieved maximal heart rate and systolic blood pressure during 
www.intechopen.com
 
The Role of Exercise Test After Percutaneous Coronary Intervention 
 
253 
physical load also showed lower parameters in the first group, which is characterized by 
double rate-pressure product compared in both groups – 212.8±42.9 and 252.62±36.9, 
accordingly, in the first and third patients’ group (p<0.05)  (Figure 4.). 
 
 
Fig. 4. Analysis of average parameters of veloergometry data (maximal heart rate, maximal 
systolic arterial pressure, maximal rate-pressure product – Robinson index). 
 
Patients’ 
groups/ 
Parameter on 
veloergometry 
Maximal 
physical 
load, W 
Maximal 
heart rate 
(when ECG 
changes 
appear) 
Maximal 
systolic 
blood 
pressure 
Robinson 
index (rate-
pressure 
product) 
ST/pulse 
index 
1. Restenosis 
(n=656) 
121.4±33.2 118.8±14.6  181.5±28.3 212.8±42.9 1.3±0.5 
2. New stenosis
(n=146) 
157.7±38.5 130.8±14.9  187.6±30.7 239.6±46.9 1.0±0.3 
3. Without 
restenosis/ new 
stenosis 
(n=806) 
160.0±25.8 135.0±40.1  189.2±23.3 252.62±36.9 0.9±0.2 
Table 1. Analysis of average parameters of veloergometry data (achieved physical load, 
maximal heart rate, maximal systolic blood pressure, Robinson index, ST/pulse index). 
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Parameters of neither maximal heart rate, nor maximal systolic arterial blood pressure, and 
so Robinson index, accordingly, are significantly lower in patients’ group witht coronary 
artery restenosis. The most important parameter, which can reflect patient’s risk of 
restenosis more precisely is ST/pulse index. In restenosis group this parameter is the 
highest one (1.3±0.5) (Table 1. and 2.). 
 
p value (between 
patients’ groups) 
Load, 
Watts 
Maximal 
heart rate 
Maximal 
systolic blood 
pressure 
Robinson 
index 
ST/pulse 
index 
First and second 
group 
< 0.05 < 0.05 0.012 < 0.05 < 0.05 
Second and third 
group 
0.396 0.118 0.48 < 0.05 0.004 
First and third 
group 
< 0.05 < 0.05 < 0.05 < 0.05 < 0.05 
Table 2. Statistical analysis in comparison of different patients’ groups. 
4.3 Patients with left main coronary artery (LM) stenosis  
The database of the patients with LM stenosis was created. 
The group of the patients (n=400) with LM stenosis and performed PCI with drug-eluting 
stents (DES) was analyzed. In a period of years 2005-2010, 133 patients accomplished 
complete follow-up programme. Veloergometry was regularly performed in 3, 6, 12 and 24 
months after PCI, also control coronarography was performed in 6-12 months after PCI. 
Clinical characteristics of the patients:  
LM patients group – 80% of the patients are males, with mean age 61.3 ± 9.8 years. The most 
part of the patients is characterized with most important risk factors of coronary artery 
disease: in 96% of cases – dyslipidemia, in 77% of cases – arterial hypertension, smoking 
habits – active smokers (18%) or ex-smokers (30.8%). Previous myocardial infarction – in 
45.1% of patients, positive family history (first-line relatives at young age with CAD) in 
36.1% of cases (Table 3.). 
All the patients underwent LM PCI: 47 patients (38%) underwent solely LM PCI and 86 
patients (65%) – also PCI additionally in other artery (Table 4.). 
The changes of the parameters registered on exercise test (maximal heart rate, maximal 
systolic blood pressure and Robinson index) in every follow-up period (independently of 
the follow-up data on coronary angiography) are showed in Table 5. 
4.3.1 Association of veloergometry results with clinical events 
Recurrent hospitalization was ascertained for 14 patients (8.3%) in analysis of clinical events 
in follow-up period. The reasons for recurrent admission to the hospital: in two cases – 
myocardial infarction, in four cases – chest pain (angina) (three of these patients underwent 
recurrent coronary angiography), in two cases – next step PCI, in two cases – heart rhythm 
disorders (in one case – implantation of permanent pacemaker), in one case – stroke, in one 
case – elevated arterial blood pressure, in two cases – non-coronary reasons for 
hospitalization.  
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Characteristics Prevalence 
Gender (males), n (%) 107 (80.5) 
Age, mea(±SD) 61.3 (± 9.8) 
Dyslipidemia, n (%) 96 (72.2) 
Arterial hypertension, n (%) 77 (57.9) 
Diabete mellitus, n (%) 11 (8.3) 
Smoking status: 
     Active smoker, n (%) 
     Ex-smoker, n (%) 
     Non-smoker, n (%) 
 
24 (18.0) 
41 (30.8) 
51 (38.3) 
Positive family history, n (%) 48 (36.1) 
Prior myocardial infarction, n (%) 60 (45.1) 
Prior PCI, n (%) 26 (19.5) 
Prior coronary artery bypass grafting, n (%) 7 (5.3) 
Table 3. Clinical characteristics of the patients (demographic parameters and risk factors of 
coronary artery disease) (n=133). 
 
Characteristics Prevalence 
Coronary artery disease: 
        One-vessel disease, n (%) 
        Two- vessel disease, n (%) 
        Three- vessel disease, n (%) 
 
51 (38.3) 
54 (40.6) 
28 (21.1) 
 
Complete/incomplete revascularization, % 40/27 
PCI LM only, n (%) 
PCI LM and other artery: 
       PCI LAD, n (%) 
47 (38.0) 
47 (35.3) 
       PCI LCx, n (%) 26 (19.5) 
       PCI RCA, n (%) 14 (10.5) 
       PCI RIM, n (%) 4 (3.0) 
       PCI D1, n (%) 3 (2.3) 
       PCI M1, RPL, RPD, n (%) 1 (0.8) 
LM–left main coronary artery; LAD–left anterior descending artery; LCx–left circumflex artery; RCA–
right coronary artery; RIM–ramus intermedius; D1–first diagonal branch; M1–first marginal branch; 
RPL–right posterolateral branch; RPD-right posterodiaphragmal branch. 
Table 4. Caracteristics of angiographic and PCI data of the patients (n=133). 
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Data of exercise test/ 
follow-up period 
1-3 months 3-6 months 6-12 months 12-24 months >24 months 
Maximal heart rate 
(bpm ± SD) 
118 ± 16 122 ± 17 121 ± 16 119 ± 15 119 ± 15 
Maximal systolic blood 
pressure (mmHg ± SD) 
180 ± 31 181 ± 29 182 ± 29 183 ± 31 184 ± 32 
Robinson index(max heart 
rate x max systolic blood 
pressure/100) ± SD  
213.27±51.02 220.93±52.55 221.55±45.9 217.84±47.68 219.32±48.46 
Table 5. Mean values of parameters analyzed on exercise test follow-up (maximal heart rate, 
maximal systolic blood pressure, Robinson index).  
Indications for control angiography were defined according to ST-segment ischemic changes 
on ECG and/or typical patients’ complaints during exercise test. 
Control angiography in follow-up period was performed in 33.8% of cases – 3-6 months 
after PCI, in 36.8% and in 10.5% of cases – 6-12 months and 12-24 months after PCI, 
respectively.   
4.3.2 Analysis of the results of control exercise tests (1-3 and 3-6 months after PCI) 
and coronary angiography 
There was no significant difference between patients group with LM restenosis and/or 
other coronary artery restenosis  on control coronary angiography and patients group 
without diagnosed restenosis, analyzing maximal achieved physical load in early follow-up 
period (control exercise test performed 1-3 and 3-6 months after PCI).  
Statistically significant difference (in maximal achieved physical load analysis) was 
observed comparing with the patients group with new coronary artery stenosis on control 
coronary angiography: these patients achieved lower maximal load on 1-3 months control 
exercise test – 90 ± 17 W vs. 129 ± 26 W, accordingly (p=0.027).   
There was no significant difference observed between patients with and without LM 
restenosis (or other artery restenosis) in analysis of achieved maximal heart rate during 
exercise test 1-3 and 3-6 months after PCI, also between patients groups with and without 
diagnosed new artery stenosis on coronary angiography (Table 6.). 
 
Maximal heart rate 
(mean ± SD) 
Exercise test control 
(months after PCI) 
‘Restenosis’ 
group 
Number 
of the 
patients
‘Non-
restenosis’ 
group 
Number 
of the 
patients
p (between 
groups) 
1-3 months 114.70 ± 8.87 10 118.49 ± 19.96 49 0.49 
3-6 months 120.93 ± 17.43 15 122.07 ± 16.92 58 0.82 
6-12 months 119.06 ± 14.63 16 120.69 ± 15.39 55 0.71 
12-24 months 112.79 ± 10.03 14 120.58 ± 15.71 38 0.09 
> 24 months 112.4 6± 13.48 13 120.74 ± 15.90 38 0.10 
Table 6. Maximal heart rate analysis in different exercise test control periods. 
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In maximal systolic blood pressure analysis, almost statistically significant difference was 
observed (trend) between ‘restenosis’ group and ‘non-restenosis’ patients group on exercise 
test 1-3 months and 3-6 months follow-ups (Table 7.). 
 
Maximal systolic blood pressure 
(mean ± SD) 
Exercise test control
(months after PCI) 
‘Restenosis’ 
group 
Number 
of the 
patients
‘Non-
restenosis’ 
group 
Number 
of the 
patients
p (between 
groups) 
1-3 months 161.70 ± 23.64 10 182.27 ± 32.32 49 0.06 
3-6 months 170.33 ± 27.55 15 185.00 ± 28.91 58 0.08 
6-12 months 176.44 ± 37.51 16 182.67 ± 26.22 54 0.45 
12-24 months 177.14 ± 30.76 14 184.16 ± 30.60 38 0.47 
> 24 months 186.92 ± 32.27 13 183.39 ± 32.90 38 0.74 
Table 7. Maximal systolic  blood pressure in different exercise test control periods. 
The difference in analysis of double product (maximal rate-pressure product) or Robinson 
index was expected, on basis of previously obtained results. The following trend was 
observed – patients with coronary artery restenosis at control coronary angiography 1-3 
months after performed PCI showed lower parameters of Robinson index. In turn, 
independently of stenosis location – LM or other coronary artery, or patients with new 
detected coronary artery stenosis – statistically significant difference and association with 
Robinson index changes between patients groups was not ascertained. 
Variability of Robinson index changes on exercise test could become possible additional 
parameter to ST-segment changes in restenosis diagnostics (Table 8., Figure 5.). 
 
Robinson index 
(mean ± SD) 
Exercise test control 
(months after PCI) 
‘Restenosis’ group ‘Non-restenosis’ 
group 
p (between 
groups) 
1-3 months 185.70 ± 32.96 217.51 ± 54.09 0.08 
3-6 months 208.12 ± 56.00 226.73 ± 53.81 0.24 
6-12 months 210.41 ± 51.57 223.22 ± 45.16 0.34 
12-24 months 197.89 ± 27.17 223.41 ± 50.73 0.08 
> 24 months 210.23 ± 46.75 221.48 ± 50.63 0.49 
Table 8. Robinson index analysis in different exercise test control periods. 
Patients with angiographically detected coronary artery stenosis have achieved lower 
physical load (in Watts), not achieving submaximal pulse, because of termination the 
veloergometry, if ischemic changes or typical chest pain is appearing. This explains the 
curve difference of Robinson index in patients with and without coronary artery restenosis, 
also, statistically significant difference between mentioned groups is not present in analysis 
of maximal achieved heart rate and maximal systolic blood pressure. However, oscillations 
of Robinson index parameters are obviously seen in patiens of ‘restenosis’ group in relative 
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1 – without restenosis on control coronary angiography 
2 – with restenosis on control coronary angiography   
Fig. 5. Analysis of different exercise test parameters (Robinson index, maximal heart rate 
and maximal systolic blood pressure) during follow-ups in patients with and without 
coronary artery restsenosis (on control angiography).  
risk period – 6-12 months follow-up. These curves repeatedly are establishing the role of 
targeted follow-up programme after performed PCI for more precise evaluation of risk of 
restenosis, taking into account not only patient’s complaints and ischemic changes on ECG, 
but also the changes of Robinson index parameters in dynamics. 
It is supposed, that the number of analyzed patients was not sufficient for statistical 
significance between groups in ST/p index analysis, in order to definitely conclude the role 
of this parameter in restenosis diagnostics (Table 9.) 
 
ST/pulse index 
(mean ± SD) 
Exercise test 
control 
‘Restenosis’ 
group 
Number 
of the 
patients
‘Non-restenosis’
group 
Number 
of the 
patients
p (between 
groups) 
1-3 months 
after PCI 
0.76 ± 0.55 10 0.59 ± 0.44 49 0.28 
3-6 months 
after PCI 
0.72 ± 0.35 15 0.61 ± 0.45 58 0.36 
6-12 months 
after PCI 
0.76 ± 0.47 16 0.59 ± 0.41 55 0.16 
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ST/pulse index 
(mean ± SD) 
Exercise test 
control 
‘New stenosis’ 
group 
Number 
of the 
patients
‘Without new 
stenosis’ group 
Number 
of the 
patients
p (between 
groups) 
1-3 months 
after PCI 
1.07 ± 0.98 6 0.57 ± 0.34 53 0.01 
3-6 months 
after PCI 
0.80 ± 0.67 7 0.61 ± 0.40 66 0.27 
6-12 months 
after PCI 
0.76 ± 0.54 11 0.61 ± 0.40 60 0.28 
Table 9. ST/pulse (ST/p) index in LM patients’ group according to angiographic finding 
(restenosis, new stenosis of coronary artery or without detected restenosis or new stenosis of 
coronary artery). 
In LM patients’ group analysis – 50% of cases of coronary artery restenosis are detected in 
early period (3-6 months after PCI), left 43% and 7% – 6-12 and 12-24 months after PCI, 
respectively. Angiographic results in early coronary angiography follow-up period (3-6 
months after performed PCI) correlate with ECG changes on 1-3 months control of physical 
test: there is statistically significant difference between patients groups – ST-segment 
depression on exercise ECG is obvious in all patients with restenosis established at control 
coronary angiography (Table 10.). 
 
 3-6 months 6-12 months 12-24 months 
Restenosis 50% 43% 7% 
ST-segment changes 
ST-segment 
depression 
ST-segment 
depression 
ST-segment 
depression 
Table 10. Restenosis and ST-segment changes on exercise ECG prior the control coronary 
angiography. 
The sensitivity of veloergometry test in 1-3 months – 29%, specificity – 100 %. Lower 
parameters of Robinson index also were registered in this patients’ group.  
Correlation of ST-segment changes with restenosis development is obvious also in later 
control of veloergometry (3-6 months after PCI). The sensitivity of veloergometry test – 50%, 
specificity – 86 %. All the patients with diagnosed new coronary artery stenosis (in other 
coronary artery) at control coronary angiography (3-6 months after PCI) showed ST-
segment depression on exercise ECG in early stress test control (1-3 months), but in patients 
group without restenosis ECG without any dynamical changes is observed in 92.9% of cases. 
The sensitivity of the test – 33%, specificity – 93 %. 
4.4 Algorithms 
Basing on the previously obtained data and on the significance of exercise test in patients’ 
follow-up after performed PCI, several algorithms were developed for evaluation of 
patients’ functional status after PCI, also for evaluation of possible treatment strategy of 
coronary artery stenosis. 
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Fig. 6. Exercise test algorithm in patients after PCI (complete revascularization). 
Patients with complete revascularization (Figure 6): 
 Exercise test should be performed in 1-3 months after PCI in patients with complete 
revscularization (performed with PCI method); 
 Patients should continue medical treatment and exercise test control every 6 months, if 
angina or ischemic changes on exercise ECG are not present; 
 Patients should undergo myocardial perfusion scintigraphy investigation or stress 
echocardiography in case of no angina, but with presentation of ischemic changes on 
exercise ECG. If ischemic changes are not present on additional examination tests, 
medical treatment shoul be continued and control of exercise test every 6 months; 
Complete revascularization
 (without hemodinamically 
significant stenosis on 
coronary angiography) 
- No typical chest pain 
- No ischemic changes on 
exercise ECG 
- No typical chest pain 
- Ischemic changes on 
exercise ECG 
 
- Typical chest pain 
- Ischemic changes on 
exercise ECG 
 
Myocardial perfusion 
scintigraphy or stress 
echocardiography (average 
4 months after PCI) 
Exercise stress test after  
1-3 and 6 months   
 
Control coronary 
angiography 
-  Medical treatment 
-  Exercise test every 6 
months 
 
No ischemic changes 
-  Medical treatment 
-  Exercise test every 6 
months 
 
Ischemic changes 
Control coronary 
angiography 
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Fig. 7. Exercise test algorithm in patients after PCI (incomplete revascularization). 
 In case of angina and ischemic changes on exercise ECG patients should undergo 
control coronary angiography. 
Patients with incomplete revascularization ( Figure 7.): 
 Exercise test should be performed in 1-3 months after PCI in patients with incomplete 
revascularization (and hemodinamically sigfnificant stenosis, left on angiography); 
 Myocardial perfusion scintigraphy investigation or stress echocardiography should be 
performed in case of no angina and no ischemic changes on exercise ECG. If ischemic 
Incomplete 
revascularization 
 (hemodinamically 
significant stenosis on 
coronary 
- No typical chest pain
- No ischemic changes 
on exercise ECG 
 
- No typical chest pain
- Ischemic changes on 
exercise ECG 
 
- Typical chest pain 
- Ischemic changes on 
exercise ECG 
 
Exercise stress test 
Next step PCI 
 (invasive cardiologist 
visit) 
Myocardial perfusion 
scintigraphy or stress 
echocardiography 
No ischemic changes 
-  Medical treatment 
-  Exercise test every 6 
months 
 
Ischemic changes 
Next step PCI 
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changes are present (in additional investigations), next step PCI should be performed. If 
ischemic changes are not present, patients should continue medical treatment and 
perform exercise test every 6 months; 
 In case of ischemic changes on exercise ECG, independently of patient’s complaints, 
next step PCI should be performed. 
 
 
Fig. 8. Exercise test algorithm in patients after LM PCI. 
Patients after left main coronary artery (LM) revascularization (Figure 8.): 
 Exercise test should be performed in 1-3 months after LM PCI. Myocardial perfusion 
scintigraphy could be performed in 4-6 months in case of inconclusive ECG; 
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myocardial perfusion 
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Myocardial perfusion 
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Ischemic changes 
Coronary angiography
No ischemic changes 
-  Medical treatment 
-  Exercise test or every 
6 months 
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 Patients should continue medical treatment and should perform exercise test every 6 
months in case of no hemodinamically significant stenosis on coronary angiography; 
 Myocardial perfusion scintigraphy investigation or stress echocardiography should be 
performed in case of ischemic changes on exercise ECG. If If ischemic changes are 
present (in additional investigations), coronary angiography should be performed. If 
ischemic changes are not present, patients should continue medical treatment and 
perform exercise test every 6 months; 
 Patients with incomplete revascularization and angiographycally with hemodynamically 
significant stenosis are left, exercise test should be performed in 1-3 months after PCI. If 
ischemic changes are not present, patients continue medical treatment and perform 
exercise test every 6 months. In case of ischemic changes on exercise test, patient should 
visit invasive cardiologist in order to make decision of next step PCI. 
5. Discussion 
In this study we raised the question whether physical exercise test alone beside accurate 
diagnosis of obstructive lesions provides an opportunity to prognose cardiovascular risk. 
We claim that this is possible, which is demonstrated in our study by a significant number 
of patients with silent ischemia. The potential gain from reducing the risk of reverse cardiac 
events is actually greatest in those with silent ischemia at the time of follow-up presentation, 
because those patients are at especially high risk (Pepine and Deedwania, 1994). Nowadays 
it is clear that chest pain in history does not correlate tightly with ischemic ST-segment 
deviation following physical loading and with haemodynamically significant stenosis on 
angiography either.  
Published data as well as national and international guidelines state that physical exercise 
test following PCI is a useful method in diagnosis of restenosis in high risk or symptomatic 
patients and should be conducted six months after intervention (Gibbons et al., 2002). Our 
results showed that the exercise test should be done not later than three to six months after 
intervention. The highest rate of restenosis was observed in patients after interventional 
treatment of LM disease in 1-3 months after procedure. The importance of the physical test 
does not decrease later; more than third part of all documented restenosis was registered at 
six months after intervention (including the patients with newly diagnosed stenosis on 
coronary angiography). One year after PCI the specific weight of restenosis was 16.7% of all 
diagnosed restenosis. 
The clinical value of exercise electrocardiograms following interventional therapy in the 
early period is high in evaluation of early post-interventional results (Roffi et al., 2003). This 
is supported with our results, which demonstrated high specificity of exercise test 
performed in the first six months after PCI. Exercise electrocardiograms 1–3 months after 
PCI did not show a shift of the ST-segment for all patients without restenosis. However, 
angiography depression of the ST-segment was registered on exercise electrocardiogram 
only for patients with restenosis. This demonstrates a clear correlation between ST-segment 
depression and restenosis.   
Adequate implementation of drug therapies depending on patient clinical and functional 
status allow to reach goals set by national and international guidelines. Based on 
epidemiological studies, even small decreases in low density lipoprotein cholesterol and 
blood pressure levels translate into significant reductions in cardiovascular morbidity and 
mortality (LaRosa et al., 2005). Moreover, especially important is the patient compliance, 
which can be achieved through frequently scheduled visits. 
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The clinical course and prognosis of patients with coronary artery disease can be modified 
favourably by successful translation of recommendations for secondary coronary prevention 
into effective clinical care. Crucial to the outcome of any preventive strategy is patient 
attitude to lifestyle modification and compliance with drug therapies over the long term. We 
tend to claim that an aggressive follow-up programme could help us to reach the goals in 
secondary prevention of coronary artery disease set by European Societies and Latvian 
Society of Cardiology. 
The physical exercise test is a safe method with high specificity, but is limited by poor test 
sensitivity for the evaluation of efficacy of interventional and medical treatment for patients 
with coronary artery disease. A focussed exercise test performed on a regular basis 
indirectly influences clinical results and prognosis. Timely set diagnosis of restenosis 
provides necessary treatment measures, therefore, alienating adverse cardiac events such as 
unstable angina and myocardial infarction. Moreover, an exercise test performed on a 
regular basis provides essential corrections in drug therapy. After comparison of drug 
therapies recommended three months and one year after PCI, we can conclude that regular 
follow-ups provide the opportunity to sustain acceptable patient compliance and use of 
medications even twelve months after an intervention. 
A focussed follow-up programme with an exercise test allows to evaluate clinical status of 
patients as well as to determine timely possible risk of restenosis, to adapt medication doses, 
to reduce risk factors and to influence positively patient compliance. The exercise test provides 
accurate estimation of possible restenosis in patients with complete revascularization. In 
patients with incomplete revascularization the exercise test specificity is reduced. Taking 
into account the results of the current study, we are sure, that focussed physical exercise test 
should be advised for all patients after interventional treatment. It is of high importance to 
achieve submaximal heart rate during the exercise test. In all cases when this is not possible 
for any reason, myocardial perfusion scintigraphy is indicated.  
Advantages of the study (benefits) 
The results of this study can be used with a goal to determine possible risk of restenosis in a 
time, to prescribe medications according to patient’s functional status, to correct possible 
risk factors, which can have negative influence on development of disease. 
Regular patients’ follow-ups increase the compliance of the patients and ‘participation’ in 
treatment process, thus increasing accuracy of data and foundation of the results. 
Possible disadvantages (limits) of the study 
Irregular patients’ follow-ups, thus exclusion from statistycal analysis. 
Insufficient information about patient recurrent hospitalization at district hospital. Also the 
variability in medical treatment (general practitioner like „middle stage” between patient 
and cardiologist). 
The lack of patients compliance in medication use, the lack of motivation in modification of 
their possible risk factors. 
Low availability of myocardial perfusion scintigraphy, thus, not possibility to perform 
necessary investigation in position of diagnosis making and more detailed evaluation of 
clinical situation. 
6. Conclusions 
1. Exercise test (veloergometry) is established as a safe method with high specificity, but 
lower sensitivity in evaluation of invasive and medical treatment efficiacy in patients 
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with CAD, evolving different invasive treatment methods (with drug-eluting stents, 
balloon angioplasty, etc.) 
2. The database of the patients with left main coronary artery stenosis was analyzed, 
evaluating the efficacy of invasive treatment of left main stenosis, analyzing possible 
progression of restenosis and evaluating following treatment steps. 
3. New specific criteria were extracted for risk evaluation and detection with exercise 
stress test. 
4. Algorithms were developed for CAD patients’ clinical status evaluation after 
percutaneous coronary intervention. 
5. Follow-up programme with targeted exercise test allows to personalize exact treatment 
strategy and risk factor correction for each patient individually.   
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